Skip to main content

Another important step for Orthocell

02/12/2024 - 15:00

Bookmark

Save articles for future reference.

Biotech firm Orthocell is a step closer to its nerve repair device Remplir being approved in the US, following the completion of its US regulatory study.

X

To read our articles you will need to either login or subscribe.